Cresset Asset Management’s CRISPR Therapeutics CRSP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $377K | Sell |
|
|||||
|
2025
Q2 | $450K | Sell |
|
|||||
|
2025
Q1 | $350K | Sell |
|
|||||
|
2024
Q4 | $592K | Sell |
|
|||||
|
2024
Q3 | $1.27M | Sell |
|
|||||
|
2024
Q2 | $1.63M | Buy |
|
|||||
|
2024
Q1 | $1.04M | Buy |
|
|||||
|
2023
Q4 | $854K | Buy |
|
|||||
|
2023
Q3 | $484K | Sell |
|
|||||
|
2023
Q2 | $602K | Buy |
|
|||||
|
2022
Q2 | – | Sell |
|
|||||
|
2022
Q1 | $236K | Sell |
|
|||||
|
2021
Q4 | $537K | Sell |
|
|||||
|
2021
Q3 | $2.21M | Buy |
|
|||||
|
2021
Q2 | $3.1M | Buy |
|
|||||
|
2021
Q1 | $2.15M | Buy |
|
|||||
|
2020
Q4 | $1.86M | Buy |
|
|||||
|
2020
Q3 | $961K | Buy |
|
|||||
|
2020
Q2 | $496K | Buy |
|